Issue Date | Title | Author(s) |
2016 | THE ASSOCIATION OF THE PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) 4G/5G POLYMORPHISM AND FACTOR V LEIDEN (FVL) MUTATION IN PEDIATRIC ACUTE LEUKEMIA PATIENTS | Akın, D. F.; Öner, D. A.; Mumcuoğlu, M.; Kürekci, E.; Ezer, U.; Akar, Mehmet Nejat |
2014 | COMPARATIVE ANALYSIS OF HDAC 2,4,5,7,8, AND 9 M-RNA EXPRESSION LEVELS IN PEDIATRIC ACUTE LEUKEMIA PATIENTS IN BEFORE AND AFTER CHEMOTHERAPY COMPARE TO HEALTHY CONTROLS | Akın, D.; Aslar, D.; Mumcuoğlu, M.; Ezer, U.; Kürekci, E.; Akar, Mehmet Nejat |
2015 | DETECTION OF TET2, KRAS, AND CBL VARIANTS BY NEXT GENERATION SEQUENCING IN CHILDHOOD ACUTE MYELOID LEUKEMIA | Akın, D. F.; Aslar, D.; Mumcuoğlu, M.; Ezer, U.; Bahce, M.; Kürekci, E.; Akar, Mehmet Nejat |
2015 | SCREENING FOR VARIATIONS IN EXONS 9, 10 AND 12 OF CD22 GENE IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA | Aslar, D.; Akın, D. F.; Mumcuoğlu, M.; Ezer, U.; Kürekci, E.; Akar, Mehmet Nejat |
2016 | SCREENING OF EPCR VARIANTS AND THEIR CORRELATION WITH FACTOR V LEIDEN AND PROTHROMBIN 20210A MUTATIONS IN TURKISH PEDIATRIC PATIENTS WITH ACUTE LEUKEMIA | Akın, D. F.; Öner, D. A.; Sipahi, K.; Mumcuoğlu, M.; Kürekci, E.; Ezer, U.; Akar, Mehmet Nejat |